ArticleBioMed research international2015
Strategy for the management of diabetic macular edema: the European vitreo-retinal society macular edema study.
Article in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 39 citations in OpenAlex.
- Pars plana vitrectomy with ILM peeling for macular edema of various etiologies: results from the SCRV macula surgery study.International ophthalmology · 2025Observational
- Pars Plana Vitrectomy and ILM Peeling for Refractory Diabetic Macular Edema Without Vitreomacular Traction.Journal of clinical medicine · 2025Article
- Real-World Outcomes of Different Types of Treatment for Diabetic Macular Edema Before and After Approval of Anti-Vascular Endothelium Growth Factor Agents.Journal of clinical medicine · 2024Article
- Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema.Journal of clinical medicine · 2023Article
- Diabetic Macular Oedema Guidelines: An Australian Perspective.Journal of ophthalmology · 2023Review
- Therapeutic Effects of Combination Therapy and Photobiomodulation Therapy on Retinal Regeneration.Journal of lasers in medical sciences · 2022Review
- Review of clinical studies and recommendation for a therapeutic flow chart for diabetic macular edema.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2021Review
- ETOILE: Real-World Evidence of 24 Months of Ranibizumab 0.5 mg in Patients with Visual Impairment Due to Diabetic Macular Edema.Clinical ophthalmology (Auckland, N.Z.) · 2021Article
- Safety and Efficacy of Ranibizumab and Luseogliflozin Combination Therapy in Patients with Diabetic Macular Edema: Protocol for a Multicenter, Open-Label Randomized Controlled Trial.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2020Article
- Clinical preferences and trends of anti-vascular endothelial growth factor treatments for diabetic macular edema in Japan.Journal of diabetes investigation · 2019Article
- Article
- Treatment trials for diabetic macular oedema.Eye (London, England) · 2016Article
- Vitrectomy for center-involved diabetic macular edema.Clinical ophthalmology (Auckland, N.Z.) · 2016Article
- An eighteen-month follow-up study on the effects of Intravitreal Dexamethasone Implant in diabetic macular edema refractory to anti-VEGF therapy.International journal of ophthalmology · 2016Article
- Corrigendum to "Strategy for the Management of Diabetic Macular Edema: The European Vitreo-Retinal Society Macular Edema Study".BioMed research international · 2015Article
- Enzymatic vitreolysis for the treatment of tractional diabetic macular edema.Therapeutic advances in ophthalmologyArticle
- Pars Plana Vitrectomy Combined with Internal Limiting Membrane Peeling to Treat Persistent Macular Edema after Anti-Vascular Endothelial Growth Factor Treatment in Cases of Ischemic Central Retinal Vein Occlusion.Case reports in ophthalmologyArticle
Corrections and comments
- Erratum issued
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo compare the efficacy of different therapies in the treatment of diabetic macular edema (DME).
designNonrandomized, multicenter clinical study.
participants86 retina specialists from 29 countries provided clinical information on 2,603 patients with macular edema including 870 patients with DME.
methodsReported data included the type and number of treatment(s) performed, the pre- and posttreatment visual acuities, and other clinical findings. The results were analyzed by the French INSEE (National Institute of Statistics and Economic Studies).
main outcome measuresMean change of visual acuity and mean number of treatments performed.
resultsThe change in visual acuity over time in response to each treatment was plotted in second order polynomial regression trend lines. Intravitreal triamcinolone monotherapy resulted in some improvement in vision. Treatment with threshold or subthreshold grid laser also resulted in minimal vision gain. Anti-VEGF therapy resulted in more significant visual improvement. Treatment with pars plana vitrectomy and internal limiting membrane (ILM) peeling alone resulted in an improvement in vision greater than that observed with anti-VEGF injection alone. In our DME study, treatment with vitrectomy and ILM peeling alone resulted in the better visual improvement compared to other therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.